ArticleJournal of clinical medicine2026

Real-World Renal and Metabolic Outcomes of SGLT-2 Inhibitor Therapy in Patients with Type 2 Diabetes Mellitus.

Öykü Ünsal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.